Efficacy and safety of tirzepatide for treatment of overweight or obesity. A systematic review and meta-analysis.
Bryan TanXin-Hui PanHan Shi Jocelyn ChewRachel Sze Jen GohChaoxing LinVickram Vijay AnandEthan Cheng Zhe LeeKai En ChanGwyneth KongChristen En Ya OngHui Charlotte ChungDan Yock YoungMark Yan-Yee ChanChin Meng KhooAnurag MehtaMark Dhinesh MuthiahMazen NoureddinCheng Han NgNicholas W S ChewYip-Han ChinPublished in: International journal of obesity (2005) (2023)
Tirzepatide has significant potential as a weight loss drug in patients with overweight and obesity, with little increase in AEs compared to other weight loss drugs. With its ability to concurrently target multiple aspects of metabolic syndrome, it should be considered as the next helm of weight loss therapies.